Annual Long Term Debt
$99.00 K
+$99.00 K+100.00%
December 31, 2023
Summary
- As of February 8, 2025, VYNE annual long term debt is $99.00 thousand, with the most recent change of +$99.00 thousand (+100.00%) on December 31, 2023.
- During the last 3 years, VYNE annual long term debt has fallen by -$33.93 million (-99.71%).
- VYNE annual long term debt is now -99.71% below its all-time high of $34.03 million, reached on December 31, 2020.
Performance
VYNE Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$0.00
-$25.00 K-100.00%
September 30, 2024
Summary
- As of February 8, 2025, VYNE quarterly long term debt is $0.00, with the most recent change of -$25.00 thousand (-100.00%) on September 30, 2024.
- Over the past year, VYNE quarterly long term debt has dropped by -$25.00 thousand (-100.00%).
- VYNE quarterly long term debt is now -100.00% below its all-time high of $34.22 million, reached on June 30, 2020.
Performance
VYNE Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
VYNE Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +100.0% | -100.0% |
| 3 y3 years | -99.7% | 0.0% |
| 5 y5 years | - | 0.0% |
VYNE Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | -100.0% | -100.0% | at low |
| 5 y | 5-year | -99.7% | -100.0% | -100.0% | at low |
| alltime | all time | -99.7% | -100.0% | -100.0% | at low |
VYNE Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $0.00(-100.0%) |
| Jun 2024 | - | $25.00 K(-60.3%) |
| Mar 2024 | - | $63.00 K(-36.4%) |
| Dec 2023 | $99.00 K(>+9900.0%) | $99.00 K(>+9900.0%) |
| Dec 2022 | $0.00 | $0.00(-100.0%) |
| Sep 2021 | - | $775.00 K(-4.6%) |
| Jun 2021 | - | $812.00 K(-97.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2021 | - | $34.06 M(+0.1%) |
| Dec 2020 | $34.03 M | $34.03 M(-0.2%) |
| Sep 2020 | - | $34.11 M(-0.3%) |
| Jun 2020 | - | $34.22 M(+2.0%) |
| Mar 2020 | - | $33.55 M(>+9900.0%) |
| Sep 2019 | - | $122.00 K(-59.5%) |
| Jun 2019 | - | $301.00 K |
FAQ
- What is VYNE Therapeutics annual long term debt?
- What is the all time high annual long term debt for VYNE Therapeutics?
- What is VYNE Therapeutics annual long term debt year-on-year change?
- What is VYNE Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for VYNE Therapeutics?
- What is VYNE Therapeutics quarterly long term debt year-on-year change?
What is VYNE Therapeutics annual long term debt?
The current annual long term debt of VYNE is $99.00 K
What is the all time high annual long term debt for VYNE Therapeutics?
VYNE Therapeutics all-time high annual long term debt is $34.03 M
What is VYNE Therapeutics annual long term debt year-on-year change?
Over the past year, VYNE annual long term debt has changed by +$99.00 K (+100.00%)
What is VYNE Therapeutics quarterly long term debt?
The current quarterly long term debt of VYNE is $0.00
What is the all time high quarterly long term debt for VYNE Therapeutics?
VYNE Therapeutics all-time high quarterly long term debt is $34.22 M
What is VYNE Therapeutics quarterly long term debt year-on-year change?
Over the past year, VYNE quarterly long term debt has changed by -$25.00 K (-100.00%)